Correlation Between Zevra Therapeutics and LadRx

Can any of the company-specific risk be diversified away by investing in both Zevra Therapeutics and LadRx at the same time? Although using a correlation coefficient on its own may not help to predict future stock returns, this module helps to understand the diversifiable risk of combining Zevra Therapeutics and LadRx into the same portfolio, which is an essential part of the fundamental portfolio management process.

By analyzing existing cross correlation between Zevra Therapeutics and LadRx, you can compare the effects of market volatilities on Zevra Therapeutics and LadRx and check how they will diversify away market risk if combined in the same portfolio for a given time horizon. You can also utilize pair trading strategies of matching a long position in Zevra Therapeutics with a short position of LadRx. Check out your portfolio center. Please also check ongoing floating volatility patterns of Zevra Therapeutics and LadRx.

Diversification Opportunities for Zevra Therapeutics and LadRx

-0.66

Correlation Coefficient

Zevra Therapeutics  LadRx

Excellent diversification

The 3 months correlation between Zevra and LadRx is -0.66. Overlapping area represents the amount of risk that can be diversified away by holding Zevra Therapeutics and LadRx in the same portfolio, assuming nothing else is changed. The correlation between historical prices or returns on LadRx and Zevra Therapeutics is a relative statistical measure of the degree to which these equity instruments tend to move together. The correlation coefficient measures the extent to which returns on Zevra Therapeutics are associated (or correlated) with LadRx. Values of the correlation coefficient range from -1 to +1, where. The correlation of zero (0) is possible when the price movement of LadRx has no effect on the direction of Zevra Therapeutics i.e., Zevra Therapeutics and LadRx go up and down completely randomly.

Pair Corralation between Zevra Therapeutics and LadRx

If you would invest  694.00  in Zevra Therapeutics on August 31, 2024 and sell it today you would earn a total of  256.50  from holding Zevra Therapeutics or generate 36.96% return on investment over 90 days.

Time Period	3 Months [change]
Direction	Moves Against
Strength	Weak
Accuracy	2.22%
Values	Daily Returns

Zevra Therapeutics  vs.  LadRx

Zevra Therapeutics

Risk-Adjusted Performance

11 of 100

OK

Compared to the overall equity markets, risk-adjusted returns on investments in Zevra Therapeutics are ranked lower than 11 (%) of all global equities and portfolios over the last 90 days. Despite somewhat weak basic indicators, Zevra Therapeutics sustained solid returns over the last few months and may actually be approaching a breakup point.

LadRx

Risk-Adjusted Performance

0 of 100

Very Weak

Over the last 90 days LadRx has generated negative risk-adjusted returns adding no value to investors with long positions. In spite of fairly strong fundamental indicators, LadRx is not utilizing all of its potentials. The current stock price disturbance, may contribute to short-term losses for the investors.

Pair Trading with Zevra Therapeutics and LadRx

The main advantage of trading using opposite Zevra Therapeutics and LadRx positions is that it hedges away some unsystematic risk. Because of two separate transactions, even if Zevra Therapeutics position performs unexpectedly, LadRx can make up some of the losses. Pair trading also minimizes risk from directional movements in the market. For example, if an entire industry or sector drops because of unexpected headlines, the short position in LadRx will offset losses from the drop in LadRx's long position.

The idea behind Zevra Therapeutics and LadRx pairs trading is to make the combined position market-neutral, meaning the overall market's direction will not affect its win or loss (or potential downside or upside). This can be achieved by designing a pairs trade with two highly correlated stocks or equities that operate in a similar space or sector, making it possible to obtain profits through simple and relatively low-risk investment.

Check out your portfolio center.

Note that this page's information should be used as a complementary analysis to find the right mix of equity instruments to add to your existing portfolios or create a brand new portfolio. You can also try the Performance Analysis module to check effects of mean-variance optimization against your current asset allocation.